October 13, 2020
CMS halts COVID-19 testing in non-CLIA-certified labs
Editor's Note
The Centers for Medicare & Medicaid Services (CMS) on October 9 announced that it is taking action to stop labs that are testing for COVID-19 without proper Clinical Laboratory Improvements Amendments (CLIA) certification.
The agency has issued 171 cease-and-desist letters to US facilities that were testing for COVID-19 without CLIA certifications in place or performing COVID-19 testing outside the scope of existing CLIA certifications.
Free Daily News
- Financial hardships a reality for some after surgery
- Marburg virus disease outbreak in Ethiopia sparks alert for readiness in US
- OR Manager Welcomes New Content Director Joe Paone to Lead Brand Into Its Next Chapter
- Health access concerns up
- AI wound care monitor detects infections early
- Leaders need to build human-centered skills
- Trends in US outpatient surgery growth
- Financial sustainability will be a major 2026 challenge
- Robotics, AI and reimbursement shifts influence ASC expansion
- Patient safety is up, so is patient acuity
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement